McKesson Corporation (NYSE:MCK) is a leading healthcare services and information technology company. It provides pharmaceuticals and medical supplies in the United States and internationally. The company plays a crucial role in the healthcare supply chain, ensuring that medications and healthcare products reach pharmacies, hospitals, and clinics efficiently. McKesson faces competition from other major players like Cardinal Health and AmerisourceBergen.
On January 14, 2026, Eric Coldwell from Robert W. Baird set a new price target for McKesson at $968. At the time, the stock was trading at approximately $833.36. This new target suggests a potential increase of about 16.16% from the current price. The stock's current price is $833.07, reflecting a slight increase of 1.10% or $9.09. Today, it has traded between $820.13 and $834.72.
GWN Securities Inc. recently acquired a new stake in McKesson, purchasing 3,570 shares valued at approximately $2.76 million during the third quarter. This acquisition was disclosed in the company's recent SEC filing. Other institutional investors and hedge funds have also adjusted their holdings in McKesson, indicating growing interest in the stock.
Solstein Capital LLC significantly increased its position in McKesson by 171.4% in the second quarter, now holding 38 shares valued at $28,000. Additionally, the State of Wyoming, GFG Capital LLC, and Delos Wealth Advisors LLC have made new investments in McKesson, with stakes valued at $29,000, $30,000, and $35,000 respectively. These investments reflect confidence in McKesson's potential growth.
McKesson's market capitalization stands at approximately $104.13 billion, highlighting its significant presence in the healthcare sector. Over the past year, the stock has reached a high of $895.58 and a low of $570.51. The trading volume for the day is 56,584 shares on the New York Stock Exchange, indicating active investor interest.
